Average Co-Inventor Count = 4.03
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Shire-nps Pharmaceuticals, Inc. (18 from 19 patents)
2. Nps Pharmaceuticals, Inc. (7 from 93 patents)
3. Nycomed Gmbh (63 patents)
25 patents:
1. 9999656 - Treatment of short bowel syndrome patients with colon-in-continuity
2. 9993528 - Treatment of short bowel syndrome patients with colon-in-continuity
3. 9987335 - Treatment of short bowel syndrome patients with colon-in-continuity
4. 9987334 - Treatment of short bowel syndrome patients with colon-in-continuity
5. 9981014 - Treatment of short bowel syndrome patients with colon-in-continuity
6. 9981015 - Treatment of short bowel syndrome patients with colon-in-continuity
7. 9981016 - Treatment of short bowel syndrome patients with colon-in-continuity
8. 9974835 - Treatment of short bowel syndrome patients with colon-in-continuity
9. 9974836 - Treatment of short bowel syndrome patients with colon-in-continuity
10. 9974837 - Treatment of short bowel syndrome patients with colon-in-continuity
11. 9974838 - Treatment of short bowel syndrome patients with colon-in-continuity
12. 9968655 - Treatment of short bowel syndrome patients with colon-in-continuity
13. 9968656 - Treatment of short bowel syndrome patients with colon-in-continuity
14. 9968657 - Treatment of short bowel syndrome patients with colon-in-continuity
15. 9968658 - Treatment of short bowel syndrome patients with colon-in-continuity